Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Core Insights - Hyperfine has received FDA clearance for a new DWI sequence, which significantly enhances the clinical capabilities of its Swoop® system in acute neurological care [1] Company Summary - The FDA clearance allows Hyperfine to expand the functionality of its Swoop® system, which is designed for use in acute neurological settings [1]